WinstonWınston
Back
U.S. Physical Therapy logo

U.S. Physical Therapy

USPH
46
Medical - Care Facilities · Healthcare
Winston Score
46
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Good
Growth
Mixed
Cash Flow
Strong
Stability
Mixed
Valuation
Good
Dividends
Mixed

Winston Score History

The full picture

U.S. Physical Therapy operates a network of outpatient physical and occupational therapy clinics across the United States. The company treats patients recovering from injuries, surgeries, and chronic conditions like back pain or sports injuries. It is one of the larger independent operators of physical therapy clinics in the country, with over 600 locations in dozens of states.

The company earns revenue primarily by billing insurance companies, Medicare, Medicaid, and patients directly for therapy sessions. Most clinics are staffed by licensed physical therapists, and the business model relies on high patient volume across its locations. Its competitive position comes partly from scale and its partnerships with physician groups and hospitals that refer patients to its clinics. The main risk the company faces is reimbursement pressure, since government and private insurers regularly adjust how much they pay per therapy visit, which directly squeezes profit margins.

Politician Trades

2 trades / 12mo

0 Congressional buys and 2 sells on USPH in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+5.5% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

-56.9% YoY

YoY Growth Rate

Earnings declining

Insider Activity

2.5%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$25M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

U.S. Physical Therapy is growing revenue at 6% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
26.6%
Modest — 26.6% gross margin
Profit after running costs
Operating Margin
12.7%
Healthy — 12.7% operating margin
Return on the money invested
ROCE
13.6%
Good — 13.6% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+11.0%
Steady sales growth (+11.0% YoY)
Profit growth
EPS YoY
-92.6%
Earnings shrinking (-92.6% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
3847%
Turns 3847% of profit into real cash
Spare cash per sale
FCF Margin
8.5%
Modest free cash flow (8.5%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.38
Conservative — low debt load (0.38)
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
460.1x
no trend
Expensive — P/E 460.1

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+431.4
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (460.1 → 28.6)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
2.27%
no trend
Moderate income — 2.27% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
+2.2%
no trend
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial